Call Me
0780 848 3333
0161 388 1961
0161 495 7000
0161 447 6600
0161 447 6700
Connect With Email
privatechestclinic@gmail.com ann.stephens@circlehealthpartners.co.uk madelaine.fox@circlehealthpartners.co.ukClinic Timing
Alexandra Hospital
Tuesday: 6.30pm - 8.30pm
Spire Manchester Hospital
Friday: 2pm - 8pm
Gavillet H, Hatfield L, Jones A, Maitra A , Horsley A, Rivett D, and van der Gast C Ecological patterns and processes of temporal turnover within lung infection microbiota. Microbiome 12, 63 (2024).
Gavillet H, Hatfield L, Rivett D, Jones A, Maitra A, Horsley A, and van der Gast C. Bacterial culture underestimates lung pathogen detection and infection status in cystic fibrosis. Microbiology Spectrum . July 2022.
Saint G L, Thomas M F, Thomas,, Abidin N Z, Langley R J, Brodlie M, McNamara P and NTM Collaborators Group. Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study. Arch Dis Childhood . October 2021.
Schofield L M, Chetcuti P, Maitra A, Moya E, and Robinson P. Improvement in lung health in primary ciliary dyskinesia. J of Paeds and Child Health . April 2021 58; 526–528.
Horsley A R, Belcher J, Bayfield K, Bianco B, Cunningham S, Fullwood C, Jones A, Shawcross A, A Smith J A, Maitra A, Gilchrist F J. Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis. Thorax June 2021.
Mills R, Rautemaa-Richardson R, Wilkinson S, Patel L, Maitra A, Alex Horsley. Impact of airway Exophiala spp. on children with cystic fibrosis. J of Cystic Fibrosis March 25, 2021.
Horsley A R, Alrumuh A, Bianco B, Bayfield K, Tomlinson J, Jones A, Maitra A, Cunningham S, Smith J, Fullwood C, Pandyan C, Gilchrist F J. Lung clearance index in healthy volunteers, measured using a novel portable system with a closed circuit wash-in. PLoS ONE 2020 15(2):e0229300.
Rosenfeld M, Wainwright C E, Higgins M, Wang L T, McKee C, , Campbell D, Tian S, Schneider J, Cunningham S, Davies J C and the ARRIVAL Study group. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. Lancet Respir Med. 2018 July ; 6(7): 545–553.
Maitra A. Severe Asthma: Challenges and Pitfalls in Management. Indian J Pediatr. 2018 May 7. doi: 10.1007/s12098-018-2686-0.
Das S, Roy S K, Mukherjee M, Maitra A, Chatterjee K, Sen S. Epidemiology of admissions with respiratory illnesses: a single tertiary centre experience. Int J Contemp Pediatr. 2017: 4(2); 1- 5
De H, Md Azad S, Giri P P, Pal P, Ghosh A and Maitra A. Case Report. Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis. Respiratory Medicine Case Reports 2017: 20; 68–7.
Khan S, Maitra A, Hissaria P, Roy S, Anand M P, Nag N and Singh H. Chronic Urticaria: Indian Context—Challenges and Treatment Options. Dermatology Research and Practice 2013: Article ID 651737, 8 pages
Sherriff A, Maitra A, Ness AR, Mattocks C, Riddoch C, Reilly JJ, Paton JY and Henderson AJ. Association of duration of television viewing in early childhood with the subsequent development of asthma. Thorax 2009: 64; 321-325.
Maitra A, Sherriff A, Northstone K, Strachan D, Henderson AJ; ALSPAC Study Team. Maternal age of menarche is not associated with asthma or atopy in prepubertal children. Thorax 2005: 60; 810 – 813.
Maitra A, Sherriff A, Strachan DP, ALSPAC Study Team and Henderson AJ. Mode of delivery is not associated with asthma or atopy in childhood. Clin Exp Allergy 2004: 34; 1349 –1355.
Maitra A, Sherriff A, Griffiths M, Henderson AJ, ALSPAC Study Team. Pertussis vaccination in infancy and asthma or allergy in later childhood – a birth cohort study. BMJ 2004: 328; 925 – 926.
Maitra A, Shine J, Henderson J, Fleming, P. The Investigation and Care of Children with Congenital Central Hypoventilation Syndrome. Current Paediatrics 2004: 14; 354-360.
Maitra A, Langton Hewer S. Acute adrenal crisis: how great is the risk? The Airways Journal: 2003: 1(2): 107
Maitra A. Assessment of airway inflammation. Essential Pediatric Pulmonology 4th Edition. New Delhi. Jaypee Brothers. 2023
Maitra A. Assessment of airway inflammation. In Kabra S, editors. Essential Pediatric Pulmonology. 3rd Edition. New Delhi. Jaypee Brothers. 2018
Maitra A. Allergic Bronchopulmonary Aspergillosis. In: Kabra S, editors. Case Based Reviews in Pediatric Pulmonology. New Delhi. Jaypee Brothers. 2017 p 93
Maitra A. Acute epiglottitis. In: Ghosh A, Mitra M, editors. Treatment and Prognosis in Pediatrics. New Delhi. Jaypee Brothers. 2013 p 90
Maitra A. Acute laryngotracehobronchitis (croup). In: Ghosh A, Mitra M, editors. Treatment and Prognosis in Pediatrics. New Delhi. Jaypee Brothers. 2013 p 93
S. Murphy, H. Wayman, L. Bates, A. Maitra, E. Gregson, A. Shawcross.Liver dysfunction in paediatric patients commencing elexacaftor/ tezacaftor/ivacaftor (ECFS 2024)
A. Maitra, E. Baker, A. Lyner, V. Ozkan, A. Farquhar, J. Gooch,A. Myrtle.Patterns of telephone inquiries to the cystic fibrosis nursing team at a large tertiary hospital in North West United Kingdom (ECFS 2024)
E. Sheppard, C. Thornton, O. Lamptey, C. Kidd, A. Maitra. An evaluation of weight loss in patients undergoing eradication therapy for Pseudomonas aeruginosa (ECFS 2024)
A Horsley, I Roberts, L Chavez, C Fullwood, AJones, A Maitra, F J Gilchrist, S Stanojevic. How much change in lung clearance index is clinically significant for people with cystic fibrosis? (BTS 2023)
G Breslin, A Maitra. Financial and logical impacts of review appointments on parents of children with cystic fibrosis (ECFS 2023)
A Maitra, C Fullwood , E Sheppard et al. Combination vitamin supplementation therapy in children with cystic fibrosis (ECFS 2023)
L Thia, R Thursfield, T Lee, J Legg, A Maitra, et al. Real-World Impact of ELX/TEZ/IVA on Quality of Life of Children With CF Aged 6-11 Years and Primary Caregivers in the UK: MAGNIFY, a Prospective, Observational, Noninterventional Study (ECFS 2023)
N Sairally, J Gooch, A Myrtle, A Farquhar, V Ozkan, A Maitra. Completeness of annual review investigations as per national recommendations after the covid pandemic – Experience from a large tertiary centre in the northwest United Kingdom (ECFS 2023)
E Sheppard, L Costello, O Otabor , B Allchi , A. Shawcross, A. Maitra The impact of modulators on Faecal Elastase in children with Cystic Fibrosis (ECFS 2023)
L Bradbury, A Maitra, A Shawcross. Cystic fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A 15-year review (ECFS 2023)
O Lamptey, C Thornton, A Maitra. N Moss Pseudomonas aeruginosa (P. aeruginosa) – a review of seasonal patterns and symptom presentation for first and new growths (ECFS 2023)
A Maitra, C Fullwood, E Sheppard, L Costello, N Hill, S Samspon, S Choudhury, A Shawcross. Combination vitamin therapy is non-inferior to individual supplementation therapy in CF. (NACFC 2022)
A Maitra, Y Tang, A Myrtle, J Gooch, SWilkinson, A Shawcross, G Mujtaba. Transition to adult care in children with cystic fibrosis – Experience over a decade from a large tertiary centre in the northwest United Kingdom (ECFS 2022)
A Maitra, H Chaudry, J Gooch, G Mujtaba. Trends in asthma diagnosis and usage of asthma medications in children with Cystic Fibrosis – Are we looking for it? (ECFS 2022)
A Maitra, J Orme-Lumsdon, C Thornton, O Lamptey, N Moss, RPlummer, A Shawcross, G Mujtaba. Parental perspectives with sending respiratory tract specimens for microbiology from home in children with Cystic Fibrosis - Experience from a Tertiary Service Provider in the Northwest United Kingdom (ECFS 2022)
D Wood and A Maitra. Anxiety and depression in children with primary ciliary dyskinesia – Experience from a tertiary respiratory centre in the northwest United Kingdom (ERS 2022)
A Maitra, C Fullwood, E Sheppard, L Costello, N Hill, S Sampson, S Choudhury, A Shawcross. Combination vitamin therapy is non-inferior to individual supplementation therapy in children with cystic fibrosis (NACFC 2022)
R Tharumakunarajah, N Francis, B Hird, L Tetlow, J Edgar, A Shawcross, G Mujtaba and A Maitra. An Evaluation of the Cystic Fibrosis Newborn Screening Service at Royal Manchester Children’s Hospital – an experience from a tertiary service provider in the United Kingdom (ECFS 2021)
H Wayman, E Yu, O Lamptey, S Wilkinson, G Mujtaba, A Maitra, A Shawcross. Detection and Management of Non-Tuberculosis Mycobacteria in cystic fibrosis patients in a tertiary paediatric centre (ECFS 2021)
G. Mujtaba, J. Edgar, A. Shawcross and A. Maitra. Cystic fibrosis children not eligible for modulators therapy – data from a tertiary paediatric centre in Northwest United Kingdom (ECFS 2021)
N Sharif, A Shawcross, E Tahsin, S Davey, A Maitra. Insights into parental experience of a specialist bronchiectasis and primary ciliary dyskinesia service provision – experience from a large tertiary paediatric centre in United Kingdom (BTS 2021)
A. Robson, A. Maitra, J. Edgar, B. Hird, L. Tetlow. Positive and borderline sweat test results for patients not referred via the newborn screening pathway: a review of patient outcomes (ECFS 2020)
H. Gavillet, L.R. Hatfield, B. Bianco, D.W. Rivett, A. Jones, A. Maitra, A. Horsley, C. van der Gast. Comparison of longitudinal sputum microbiology culture with high-throughput PCR-based sequencing (ECFS 2020)
A.A.M. Hafiz, A. Forster, E. Turner, E. Sheppard, S. Wilkinson, A. Maitra, A. Shawcross.1Results of a change in vitamin supplementation for cystic fibrosis patients in a tertiary paediatric centre (ECFS 2020)
A Horsley, C Fullwood, B Bianco, A Maitra, et al. Repeatability of LCI in routine outpatient clinics. First report of LCI-SEARCH study. (ECFS Liverpool, 2019)
AmnahAlrumuh, Francis Gilchrist, Brooke Bianco, Katie Bayfield, Joanne Tomlinson, Andrew Jones, Anirban Maitra, et al. Normative values of LCI in children and adults using SF6 as washout gas (ECFS Liverpool, 2019)
L. Buttarazzi , C. Fullwood , G. Mujtaba , J. Edgar , C. Thornton , O. Narayan , A. Maitra. Oral Steroids versus Pulsed Methylprednisolone in Allergic Bronchopulmonary Aspergillosis - 10 years' experience from a large tertiary Paediatric Cystic Fibrosis centre (ECFS Liverpool, 2019)
P. Koushi, G. Mujtaba, J. Edgar, A. Maitra. Assessing sleep disordered breathing in asymptomatic and stable children with cystic fibrosis - findings from a pilot study (ECFS Liverpool, 2019)
A Maitra, Z Begum, J Edgar, A Shawcross, G Mujtaba. Behavioural problems in children with Cystic Fibrosis – Are we really looking for it? (ECFS Liverpool, 2019)
G. Mujtaba, E. Sheppard, S. Crook, L. Costello, E. Skelton, A.Maitra. Short gut syndrome and Bacterial Overgrowth in Children with Cystic Fibrosis - - Experience from a tertiary Paediatric CF Centre (ECFS Liverpool, 2019)
G.Mujtaba, S.Sehabi. A.Maitra. Use of gastric acid lowering agents in children with cystic fibrosis - are we over treating? (ECFS Liverpool, 2019)
J. Gooch1, L. Turnbull1, C. Fullwood, A. Maitra. Non-tuberculous mycobacteria infection in children with cystic fibrosis - experience from a large tertiary centre in United Kingdom. (ECFS Seville, Spain 2017)
AR Horsley, A Shawcross, M Oladapo, A Maitra, S Cunningham, AM Jones, J Smith, F Gilchrist. Reproducibility of lung clearance index (LCI) in clinically stable adults with mild cystic fibrosis (CF). (BTS Winter Meeting, London, Dec 2016)
A Maitra, A Sherriff, AJ Henderson . Size at birth, asthma symptoms and respiratory function in a cohort of prepubertal children. (BTS Winter Meeting, London, Dec 2009)
A Maitra, A Sherriff, AJ Henderson. The relationship of asthma, atopy and adiposity in prepubertal children. (BTS Winter Meeting, London, Dec 2008)
A Maitra, A Sherriff, AJ Henderson . Socio-economic position, lung function and bronchial responsiveness in prepubertal children. (ERS Congress, Stockholm, Sweden Sep 2007)
A. Maitra, L. Miller, M. Wright, H. Thomas, A. Preece, D. Henshaw. Corona ions from high voltage power lines are not associated with adverse effects on lung health, asthma, or atopy in young children: a longitudinal birth cohort study (BTS Winter Meeting, London Dec 2005)